Literature DB >> 21046246

Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?

Javier Molina-Infante, Belen Perez-Gallardo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21046246     DOI: 10.1007/s10620-010-1440-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Thalidomide-induced fulminant hepatic failure.

Authors:  Mehdi Hamadani; Don M Benson; Edward A Copelan
Journal:  Mayo Clin Proc       Date:  2007-05       Impact factor: 7.616

Review 2.  Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

Authors:  Majid Almadi; Peter M Ghali; Andre Constantin; Jacques Galipeau; Andrew Szilagyi
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

3.  Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.

Authors:  J Bauditz; H Lochs; W Voderholzer
Journal:  Endoscopy       Date:  2006-10       Impact factor: 10.093

Review 4.  Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies.

Authors:  Colin Brown; Venkataraman Subramanian; C Mel Wilcox; Shajan Peter
Journal:  Dig Dis Sci       Date:  2010-08       Impact factor: 3.199

5.  A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias.

Authors:  Vrushali Dabak; Philip Kuriakose; Ginny Kamboj; Muhammad Shurafa
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  [Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities].

Authors:  Javier Molina Infante; Belén Pérez Gallardo; Moisés Hernández Alonso; José María Mateos Rodríguez; Carmen Dueñas Sadornil; Miguel Fernández Bermejo
Journal:  Med Clin (Barc)       Date:  2009-09-25       Impact factor: 1.725

7.  Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.

Authors:  Patarapong Kamalaporn; Ramasamy Saravanan; Maria Cirocco; Gary May; Paul Kortan; Gabor Kandel; Norman Marcon
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566

  7 in total
  1 in total

1.  Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations.

Authors:  Antonio Garrido Serrano; Rafael León; Manuel Sayago; Jose Luis Márquez
Journal:  Dig Dis Sci       Date:  2012-04       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.